Now is the time to upgrade for more discovery power. Support and reagent availability for HiSeq 1000–3000 Systems ends February 28, 2023. Contact us to see if you qualify for a trade-in or use our Sequencing Platform Comparison Tool to find the best instrument for your needs.
HiSeq SBS Kit v4 kits contain ready-to-load reagents for accurately determining the DNA sequence of each cluster on a flow cell using sequencing by synthesis (SBS) technology on enabled HiSeq sequencing systems* run in high output mode.
HiSeq v4 chemistry allows all reagents to be loaded onto the instrument before beginning the run. To perform a HiSeq v4 run, you need 1 HiSeq SBS Kit v4. Each kit includes sufficient reagents for sequencing 1 flow cell.
*HiSeq Systems require the latest hardware configuration. Check with your local sales rep regarding system compatibility.
Note: This kit is NOT compatible with the Genome Analyzer.
You can choose from single-read or paired-end read runs, with read lengths up to 2×125 bp in high output mode. If longer read lengths are desired, rapid run SBS kits enable up to 2×250 bp.
These kits enable a wide variety of applications, from ChIP-Seq to whole-genome sequencing, splice variant detection, and more. They enable researchers, in a single run, to process up to†:
This product is also available as an Illumina Advantage (TG) product. Illumina Advantage large-scale sequencing products feature lot-specific shipments and testing, extended shelf life, and advanced change notifications for greater laboratory efficiency.
†Assumes 100 Gb per genome at 2x125 bp, 5 Gb per exome at 2x100 bp with TruSeq Exome or TruSeq Rapid Exome kits, and 50 million reads per transcriptome.
If you currently own a HiSeq 2500, HiSeq 3000/4000, or HiSeq X, you may be eligible to trade in your existing instrument for a new NovaSeq 6000 System. This program is available for a limited time only. Terms and conditions apply. Fill out the form below to contact a sales representative to see if you are eligible.
文献目前不适用于该产品
Scalable throughput and flexibility for virtually any genome, sequencing method, and scale of project.
Learn More